Real-world bleeding rates on emicizumab: the value of using nationwide digital treatment diary data in clinical research

Bleeding rates among Dutch people with severe hemophilia A using emicizumab were comparable to other real-world studies. We formulated recommendations to improve the quality of patient-reported bleeding data, such as establishing guidelines for recording bleeds and improving interoperability.

Authors

Institutions

Publication Details

Journal
Research and Practice in Thrombosis and Haemostasis
Published
2025-02-01
DOI
https://doi.org/10.1016/j.rpth.2025.102717
Citations
5
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
8.85

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world bleeding rates on emicizumab: the value of using nationwide digital treatment diary data in clinical research

M.H.E. Driessens, M. Beijlevelt, Paul L. den Exter, Elisabeth M. Taal et al.
5 citations
Research and Practice in Thrombosis and Haemostasis
Hemophilia Treatment and Research
8.85
article

Real-world bleeding rates on emicizumab: the value of using nationwide digital treatment diary data in clinical research

M.H.E. Driessens, M. Beijlevelt, Paul L. den Exter, Elisabeth M. Taal, Martijn R Brands, Marjet A Stein-Wit, Marieke J. H. A. Kruip, Kathelijn Fischer, Samantha C. Gouw, Karina Meijer, Stephan Meijer, Karin Fijnvandraat, Britta A. P. Laros‐van Gorkom, Martijn Oude Voshaar, Caroline M E van Veen
article en
5 citations

Abstract

Bleeding rates among Dutch people with severe hemophilia A using emicizumab were comparable to other real-world studies. We formulated recommendations to improve the quality of patient-reported bleeding data, such as establishing guidelines for recording bleeds and improving interoperability.

Research and Practice in Thrombosis and HaemostasisVol. 9(2)
University Medical Center Groningen (NL), Radboud University Nijmegen (NL), University of Groningen (NL), Utrecht University (NL), Dutch Cancer Society (NL), Leiden University Medical Center (NL), Erasmus MC (NL), Radboud University Medical Center (NL), University Medical Center Utrecht (NL), Sanquin (NL), Amsterdam Neuroscience (NL), Amsterdam University Medical Centers (NL), Hersenstichting (NL), University of Amsterdam (NL)
Pfizer, CSL Behring, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Novo Nordisk, Swedish Orphan Biovitrum, Aard- en Levenswetenschappen, Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zero hunger
Openalex Percentile: Top 3%
Hemophilia Treatment and Research
8.85
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.